Uncategorized

Two Stocks in Concentration: Foamix Pharmaceuticals Ltd. (NASDAQ:FOMX) & Lamb Weston Holdings, Inc. (NYSE:LW)

Foamix Pharmaceuticals Ltd. (NASDAQ:FOMX)

Foamix Pharmaceuticals Ltd. is a specialty pharmaceutical company. It develops and commercializes foam-based formulations acne, impetigo, and other skin conditions. The Company’s lead product candidates include FMX101, which has completed a dose-ranging Phase II clinical trial for the treatment of moderate-to-severe acne; and FMX102 that has completed a Phase II clinical trial for the treatment of impetigo. It has operations primarily in the United States, Germany, and Israel. Foamix Pharmaceuticals Ltd. is headquartered in Rehovot, Israel.

Foamix Pharmaceuticals Ltd. (NASDAQ:FOMX)’s Financial Overview

Foamix Pharmaceuticals Ltd. (NASDAQ) surged 0% yesterday to close its trading session at $3.55. The company has 1 year Price Target of $15.5. Foamix Pharmaceuticals Ltd. has 52-Week high of $7.6 and 52-Week Low of $3.21. The stock touched its 52-Week High on 7.60 and 52-Week Low on 3.21. The stock traded with the volume of 127849 shares yesterday. The firm shows the market capitalization of $191.06 Million.

Foamix Pharmaceuticals Ltd. (NASDAQ) reported its last quarterly earnings on 9/29/2018 where the firm reported its Actual EPS of $-0.38/share against the analyst consensus estimate of $-0.47/share. The difference between the actual and expected EPS is $0.09 a share with a surprise factor of 19.1%.

The firm is trading with SMA20 of -2.94 Percent, SMA50 of -5.61 Percent and SMA200 of -27.28 percent. Foamix Pharmaceuticals Ltd. has P/S value of 50.28 while its P/B value stands at 1.38. Similarly, the company has Return on Assets of -99.3 percent, Return on Equity of -118.3 percent and Return on Investment of -97.3 Percent. The company shows Gross Margin and Operating Margin of 99.9 percent and 0 percent respectively.

The Stock currently has Analyst’ mean Recommendation of 1.8 where the scale is from 1 to 5, 1 means Strong Buy and 5 means Sell.

The 5 analysts offering 12-month price forecasts for Foamix Pharmaceuticals Ltd have a median target of 12.00, with a high estimate of 30.00 and a low estimate of 9.00. The median estimate represents a +238.03% increase from the last price of 3.55.

Foamix Pharmaceuticals Ltd. is estimated to report earnings on 02/27/2019. The upcoming earnings date is derived from an algorithm based on a company’s historical reporting dates.Our vendor, Zacks Investment Research, might revise this date in the future, once the company announces the actual earnings date. According to Zacks Investment Research, based on 2 analysts’ forecasts, the consensus EPS forecast for the quarter is $-0.26. The reported EPS for the same quarter last year was $-0.46.

Lamb Weston Holdings, Inc. (NYSE:LW)

Lamb Weston Holdings, Inc. is a supplier of frozen potato, sweet potato, appetizer and vegetable products to restaurants and retailers. Lamb Weston Holdings, Inc. is headquartered in Eagle, Idaho.

Lamb Weston Holdings, Inc. (NYSE:LW)’s Financial Outlook

The 5 analysts offering 12-month price forecasts for Lamb Weston Holdings Inc have a median target of 82.00, with a high estimate of 85.00 and a low estimate of 74.00. The median estimate represents a +18.81% increase from the last price of 69.02.

Lamb Weston Holdings, Inc. is estimated to report earnings on 04/04/2019. The upcoming earnings date is derived from an algorithm based on a company’s historical reporting dates.Our vendor, Zacks Investment Research, might revise this date in the future, once the company announces the actual earnings date. According to Zacks Investment Research, based on 3 analysts’ forecasts, the consensus EPS forecast for the quarter is $0.82. The reported EPS for the same quarter last year was $0.91.

According to Zacks Investment Research, Lamb Weston Holdings, Inc. has a Consensus Recommendation of 1.8. (The Scale is from 1-5 where 1 means Strong Buy and 5 means Strong Sell).

The Stock declined -1.95% and closed its last trading session at $69.02. The company has the market capitalization of $10.11 Billion. The stock has 52-week high of $83.86 and 52-Week low of $53.29. The firm touched its 52-Week high on 83.86 and 52-Week low on 53.29. The company has volume of 1.52 Million shares. The company has a total of 146.47 Million shares outstanding.

Lamb Weston Holdings, Inc. (NYSE) in the last quarter reported its actual EPS of $0.8/share where the analyst estimated EPS was $0.72/share. The difference between the actual and Estimated EPS is $0.08. This shows a surprise factor of 11.1 percent.

The company has YTD performance of -6.17 percent. Beta for Lamb Weston Holdings, Inc. stands at 0 while its ATR (average true range) is 1.54. The company has Weekly Volatility of 1.60%% and Monthly Volatility of 2.03%%.

Lamb Weston Holdings, Inc. has distance from 20-day Simple Moving Average (SMA20) of -2.89%, Distance from 50-Day Simple Moving Average of -5.21 percent and Distance from 200-Day Simple Moving Average of -2.68%.

The Company currently has ROA (Return on Assets) of 16.5 percent, Return on Equity (ROE) of -165.4 Percent and Return on Investment (ROI) of 18.8% with Gross margin of 26.4 percent and Operating & Profit margin of 17.4% and 13.1% respectively.